FMTO
Femto Technologies Inc. Common StockFMTO
FMTO
About: Femto Technologies Inc is an integrated software company. It owns and markets Benefit CRM, a proprietary customer relationship management CRM software product enabling small and medium sized businesses to optimize their day to day business activities such as sales management, personnel management, marketing, call center activities, and asset management.
Employees: 7
0
Funds holding %
of 7,363 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
0.14% less ownership
Funds ownership: 0.25% [Q3] → 0.11% (-0.14%) [Q4]
25% less funds holding
Funds holding: 4 [Q3] → 3 (-1) [Q4]
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
55% less capital invested
Capital invested by funds: $13.2K [Q3] → $5.9K (-$7.28K) [Q4]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Research analyst outlook
We haven’t received any recent analyst ratings for FMTO.
Financial journalist opinion
Neutral
TheNewswire
1 week ago
Femto Technologies Inc. Announces Closing of $17 Million Private Placement
ASHKELON, ISRAEL AND VANCOUVER, BRITISH COLUMBIA – TheNewswire - FEBRUARY 28, 2025 - Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera , a feminine wellness product, today announced the closing of its previously announced private placement of approximately $17 million of Common Shares (also known as Subordinate Voting Shares under British Columbia corporation law) and pre-funded and investor warrants at a price of $4.17 per Common Unit. The offering consisted of the sale of 4,076,736 Common Units (or Pre-Funded Units), each consisting of (i) one Common Share or Pre-Funded Warrant, (ii) one Series A Warrant to purchase one Common Share per warrant and (iii) one Series B Warrant to purchase one Common Share per warrant. The offering price per Common Unit was $4.17 (or $4.16999 for each Pre-Funded Unit, which is equal to the offering price per Common Unit sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants are immediately exercisable and may be exercised at any time. The initial exercise price of each Series A Warrant is $5.21 per Common Share. The Series A Warrants are exercisable immediately and have a term of 60 months. The number of securities issuable under the Series A Warrants is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering. The initial exercise price of each Series B Warrant is $12.51 per Common Share or pursuant to an alternative cashless exercise option. The Series B Warrants are immediately exercisable and have a term of 30 months. The number of securities issuable under the Series B Warrants is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering.
Neutral
TheNewswire
1 week ago
Femto Technologies Inc. Announces $17 Million Private Placement.
ASHKELON, ISRAEL AND VANCOUVER, BRITISH COLUMBIA – FEBRUARY 26, 2025 - TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera , a feminine wellness product, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of approximately $17 million of Common Shares (also known as Subordinate Voting Shares under British Columbia securities law) and pre-funded and investor warrants at a price of $4.17 per Common Unit. The offering consisted of the sale of Common Units (or Pre-Funded Units), each consisting of (i) one (1) Common Share or Pre-Funded Warrant, (ii) 1 Series A Warrants to purchase one (1) Common Share per warrant and (iii) 1 Series B PIPE Common Warrants to purchase one (1) Common Share per warrant. The offering price per Common Unit is $4.17 (or $4.16999 for each Pre-Funded Unit, which is equal to the offering price per Common Unit sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Unit sold in the offering, the number of Common Units in the offering will be decreased on a one-for-one basis. The initial exercise price of each Series A Common Warrant is $5.21 per Common Share. The Series A Common Warrants are exercisable immediately and expire 60 months after the initial issuance date. The number of securities issuable under the Series A Common Warrant is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering. The initial exercise price of each Series B Common Warrant is $12.51 per Common Share or pursuant to an alternative cashless exercise option. The Series B Common Warrants are exercisable immediately and expire 30 months after the initial issuance date. The number of securities issuable under the Series B Common Warrant is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering.
Neutral
TheNewswire
1 month ago
Femto Technologies Inc. Announces RSU Grant
VANCOUVER, BC – February 7, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a Femtech pioneer and the creator of Sensera , a feminine wellness product, today announced that as part of the Company's policy to preserve the human capital employed in the Company, which is the driving force behind the constant activity and development in which the Company has been and continues to be engaged, and in order to deepen the Company's commitment to its employees, consultants and directors (and vice versa), the Company's board of directors (the “ Board ”) has approved the grant, to employees, directors and consultants of the Company, of 188,000 restricted share units (“ RSUs ”) pursuant to the Company's restricted share unit plan. The Board's approval of the grant of RSUs was also based on the recommendation of the Company's Governance, Nominating and Compensation Committee made on February 5, 2025. Each RSU entitles the holder to acquire one subordinate voting share of the Company, all of which shares will be subject to a 12-month lock-up. The RSUs vested immediately upon grant.
Charts implemented using Lightweight Charts™